{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:20:03Z","timestamp":1785831603220,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"New York State Council of Health-System Pharmacists Research and Education Foundation Research Awards"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40360-018-0240-3","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T10:07:01Z","timestamp":1533550021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-7524","authenticated-orcid":false,"given":"Victoria","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorg J.","family":"Ruhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Fedorenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"240_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1155\/2013\/205910","volume":"24","author":"KB Laupland","year":"2013","unstructured":"Laupland KB, Valiquette L. Outpatient parenteral antimicrobial therapy. Can J Infect Dis Med Microbiol. 2013;24:9\u201311.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"240_CR2","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1086\/420939","volume":"38","author":"AD Tice","year":"2004","unstructured":"Tice AD, Rehm S, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, Gainer RB, Kunkel MJ, Yancey RW, Williams DN. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2004;38:1651\u201372.","journal-title":"Clin Infect Dis"},{"key":"240_CR3","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1086\/653520","volume":"51","author":"JA Paladino","year":"2010","unstructured":"Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010;51:S198\u2013208.","journal-title":"Clin Infect Dis"},{"key":"240_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/cid\/cit920","volume":"58","author":"GM Allison","year":"2014","unstructured":"Allison GM, Muldoon EG, Kent DM, Paulus JK, Ruthazer R, Ren A, Snydman DR. Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clin Infect Dis. 2014;58:812\u20139.","journal-title":"Clin Infect Dis"},{"key":"240_CR5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/phar.1799","volume":"36","author":"L Means","year":"2016","unstructured":"Means L, Bleasdale S, Sikka M, Gross AE. Predictors of hospital readmission in patients receiving outpatient parenteral antimicrobial therapy. Pharmacotherapy. 2016;36:934\u20139.","journal-title":"Pharmacotherapy"},{"key":"240_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/cid\/cit211","volume":"57","author":"EJC Goldstein","year":"2013","unstructured":"Goldstein EJC, Muldoon EG, Snydman DR, Penland EC, Allison GM. Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence. Clin Infect Dis. 2013;57:419\u201324.","journal-title":"Clin Infect Dis"},{"key":"240_CR7","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1093\/jac\/dkq355","volume":"65","author":"J Ho","year":"2010","unstructured":"Ho J, Archuleta S, Sulaiman Z, Fisher D. Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service. J Antimicrob Chemother. 2010;65:2641\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"240_CR8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1093\/jac\/dkt046","volume":"68","author":"CJA Duncan","year":"2013","unstructured":"Duncan CJA, Barr DA, Ho A, Sharp E, Semple L, Seaton RA. Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis. J Antimicrob Chemother. 2013;68:1650\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"240_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/jac\/dkt303","volume":"69","author":"D Huck","year":"2014","unstructured":"Huck D, Ginsberg JP, Gordon SM, Nowacki AS, Rehm SJ, Shrestha NK. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme. J Antimicrob Chemother. 2014;69:228\u201333.","journal-title":"J Antimicrob Chemother"},{"key":"240_CR10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/jac\/dkp343","volume":"64","author":"AL Chapman","year":"2009","unstructured":"Chapman AL, Dixon S, Andrews D, Lillie PJ, Bazaz R, Patchett JD. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64:1316\u201324.","journal-title":"J Antimicrob Chemother"},{"key":"240_CR11","first-page":"494","volume":"55","author":"E Cheung","year":"2009","unstructured":"Cheung E, Baerlocher MO, Asch M, Myers A. Venous access: a practical review for 2009. Can Fam Physician. 2009;55:494\u20136.","journal-title":"Can Fam Physician"},{"key":"240_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jemermed.2016.05.029","volume":"51","author":"DZ Adams","year":"2016","unstructured":"Adams DZ, Little A, Vinsant C, Khandelwal S. The midline catheter: a clinical review. J Emerg Med. 2016;51:252\u20138.","journal-title":"J Emerg Med"},{"key":"240_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ijnurstu.2013.09.002","volume":"51","author":"R Sharp","year":"2014","unstructured":"Sharp R, Esterman A, McCutcheon H, Hearse N, Cummings M. The safety and efficacy of midlines compared to peripherally inserted central catheters for adult cystic fibrosis patients: a retrospective, observational study. Int J Nurs Stud. 2014;51:694\u2013702.","journal-title":"Int J Nurs Stud"},{"key":"240_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S1051-0443(07)61865-X","volume":"13","author":"N Moureau","year":"2002","unstructured":"Moureau N, Poole S, Murdock MA, Gray SM, Semba CP. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol. 2002;13:1009\u201316.","journal-title":"J Vasc Interv Radiol"},{"key":"240_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373\u201383.","journal-title":"J Chron Dis"},{"key":"240_CR16","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1001\/jama.2014.13513","volume":"312","author":"MD Neuman","year":"2014","unstructured":"Neuman MD, Wirtalla C, Werner RM. Skilled nursing facility quality and hospital readmissions. JAMA. 2014;312:1542\u201351.","journal-title":"JAMA"},{"key":"240_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1377\/hlthaff.2009.0629","volume":"29","author":"V Mor","year":"2010","unstructured":"Mor V, Intrator O, Feng Z, Grabowski DC. The revolving door of rehospitalization from skilled nursing facilities. Health Aff (Millwood). 2010;29:57\u201364.","journal-title":"Health Aff (Millwood)"},{"key":"240_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1532-5415.2010.02768.x","volume":"58","author":"JG Ouslander","year":"2010","unstructured":"Ouslander JG, Lamb G, Perloe M, Givens JH, Kluge L, Rutland T, Atherly A, Saliba D. Potentially avoidable hospitalizations of nursing home residents: frequency, causes, and costs. J Am Geriatr Soc. 2010;58:627\u201335.","journal-title":"J Am Geriatr Soc"},{"key":"240_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/jgs.14557","volume":"65","author":"EE Vasilevskis","year":"2017","unstructured":"Vasilevskis EE, Ouslander JG, Mixon AS, Bell SP, Jacobsen JM, Saraf AA, Markley D, Sponsler KC, Shutes J, Long EA, Kripalani S, Simmons SF, Schnelle JF. Potentially avoidable readmissions of patients discharged to post-acute care: perspectives of hospital and skilled nursing facility staff. J Am Geriatr Soc. 2017;65:269\u201376.","journal-title":"J Am Geriatr Soc"},{"key":"240_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/NCM.0b013e3181f3f684","volume":"16","author":"B Jacobs","year":"2011","unstructured":"Jacobs B. Reducing heart failure hospital readmissions from skilled nursing facilities. Prof Case Manag. 2011;16:18\u201324.","journal-title":"Prof Case Manag"},{"key":"240_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1086\/676859","volume":"35","author":"MA Lane","year":"2014","unstructured":"Lane MA, Marschall J, Beekmann SE, Polgreen PM, Banerjee R, Hersh AL, Babcock HM. Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians. Infect Control Hosp Epidemiol. 2014;35:839\u201344.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"240_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/00365548.2014.967290","volume":"47","author":"EG Muldoon","year":"2015","unstructured":"Muldoon EG, Switkowski K, Tice A, Snydman DR, Allison GM. A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT). Infect Dis (Lond). 2015;47:39\u201345.","journal-title":"Infect Dis (Lond)"},{"key":"240_CR23","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.2146\/ajhp150201","volume":"73","author":"EK Chung","year":"2016","unstructured":"Chung EK, Beeler CB, Muloma EW, Osterholzer D, Damer KM, Erdman SM. Development and implementation of a pharmacist-managed outpatient parenteral antimicrobial therapy program. Am J Health-Syst Pharm. 2016;73:e24\u201333.","journal-title":"Am J Health-Syst Pharm"},{"key":"240_CR24","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1345\/aph.1Q240","volume":"45","author":"BH Heintz","year":"2011","unstructured":"Heintz BH, Halilovic J, Christensen CL. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Ann Pharmacother. 2011;45:1329\u201337.","journal-title":"Ann Pharmacother"},{"key":"240_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/8755122513500922","volume":"29","author":"SC Keller","year":"2013","unstructured":"Keller SC, Ciuffetelli D, Bilker W, Norris A, Timko D, Rosen A, Myers JS, Hines J, Metlay J. The impact of an infectious diseases transition service on the care of outpatients on parenteral antimicrobial therapy. J Pharm Technol. 2013;29:205\u201314.","journal-title":"J Pharm Technol"},{"key":"240_CR26","doi-asserted-by":"publisher","first-page":"ofx097","DOI":"10.1093\/ofid\/ofx097","volume":"4","author":"T Madaline","year":"2017","unstructured":"Madaline T, Nori P, Mowrey W, Zukowski E, Gohil S, Sarwar U, Weston G, Urrely R, Palombelli M, Pierino VF, Parsons V, Ehrlich A, Ostrowsky B, Corpuz M, Pirofski L. Bundle in the Bronx: Impact of a transition-of-care outpatient parenteral antibiotic therapy bundle on all-cause 30-day hospital readmissions. Open Forum Infect Dis. 2017;4:ofx097.","journal-title":"Open Forum Infect Dis"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-018-0240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-018-0240-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-018-0240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T19:16:56Z","timestamp":1565032616000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-018-0240-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["240"],"URL":"https:\/\/doi.org\/10.1186\/s40360-018-0240-3","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was determined by the Institutional Review Board (Mount Sinai School of Medicine IRB#7 \u2013 NFL \u2013 ID# IRB-16-00831) to be an exempt study, as this was a non-interventional, retrospective study with no direct patient interaction. Patient consent to participate was determined to not be required, as patient identifiers were not recorded in the study, and there was minimal risk for loss of confidentiality.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"50"}}